XML 72 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Statements of Comprehensive Loss - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Net loss $ (11,392,857) $ (17,176,644) $ (47,782,363) $ (43,776,220)
Available for sale securities - net unrealized loss (988) (886) (451) 112
Total other comprehensive loss (988) (886) (451) 112
Comprehensive loss (11,393,845) (17,177,530) (47,782,814) (43,776,108)
Comprehensive loss attributable to noncontrolling interests (16,908) (202,375) (93,257) (514,877)
Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders $ (11,376,937) $ (16,975,155) $ (47,689,557) $ (43,261,231)